tiprankstipranks
Trending News
More News >
Careium AB (SE:CARE)
:CARE
Sweden Market
Advertisement

Careium AB (CARE) Stock Forecast & Price Target

Compare
1 Followers
See the Price Targets and Ratings of:

CARE Financial Forecast

CARE Earnings Forecast

Next quarter’s earnings estimate for CARE is kr0.65 with a range of kr0.65 to kr0.65. The previous quarter’s EPS was kr0.35. CARE beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.09% of the time in the same period. In the last calendar year CARE has Performed in-line its overall industry.
Next quarter’s earnings estimate for CARE is kr0.65 with a range of kr0.65 to kr0.65. The previous quarter’s EPS was kr0.35. CARE beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.09% of the time in the same period. In the last calendar year CARE has Performed in-line its overall industry.

CARE Sales Forecast

Next quarter’s sales forecast for CARE is kr237.00M with a range of kr237.00M to kr237.00M. The previous quarter’s sales results were kr213.70M. CARE beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 47.55% of the time in the same period. In the last calendar year CARE has Performed in-line its overall industry.
Next quarter’s sales forecast for CARE is kr237.00M with a range of kr237.00M to kr237.00M. The previous quarter’s sales results were kr213.70M. CARE beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 47.55% of the time in the same period. In the last calendar year CARE has Performed in-line its overall industry.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TR | OpenAI - 4o Analyst forecast on SE:CARE
TR | OpenAI - 4o
TR | OpenAI - 4o
kr31kr27
Hold
5.47%
Upside
Downgraded
11/07/25
AI Generated ArticleAI Generated Article
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TR | OpenAI - 4o Analyst forecast on SE:CARE
TR | OpenAI - 4o
TR | OpenAI - 4o
kr31kr27
Hold
5.47%
Upside
Downgraded
11/07/25
AI Generated ArticleAI Generated Article
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Careium AB

1 Month
xxx
Success Rate
0/1 ratings generated profit
0%
Average Return
-6.70%
upgraded a xxx
rating 17 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 0.00% of your transactions generating a profit, with an average return of -6.70% per trade.
3 Months
xxx
Success Rate
0/1 ratings generated profit
0%
Average Return
-6.70%
upgraded a xxx
rating 17 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 0.00% of your transactions generating a profit, with an average return of -6.70% per trade.
1 Year
Colt ShieldwynTR | OpenAI - 4o
Success Rate
0/1 ratings generated profit
0%
Average Return
-6.70%
upgraded a buy rating 17 days ago
Copying Colt Shieldwyn's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -6.70% per trade.
2 Years
xxx
Success Rate
0/1 ratings generated profit
0%
Average Return
-6.70%
upgraded a xxx
rating 17 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -6.70% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

CARE Analyst Recommendation Trends

Rating
Aug 25
Oct 25
Nov 25
Strong Buy
0
0
0
Buy
0
0
0
Hold
2
4
5
Sell
0
0
0
Strong Sell
0
0
0
total
2
4
5
In the current month, CARE has received 0 Buy Ratings, 5 Hold Ratings, and 0 Sell Ratings. CARE average Analyst price target in the past 3 months is .
Each month's total comprises the sum of three months' worth of ratings.

CARE Stock Forecast FAQ

What is SE:CARE’s average 12-month price target, according to analysts?
Currently, no data Available
What is SE:CARE’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for SE:CARE, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is Careium AB a Buy, Sell or Hold?
      Careium AB has a consensus rating of Hold, which is based on 0 buy ratings, 0 hold ratings and 0 sell ratings.
        What is Careium AB’s share price target?
        Currently, no data Available
        What do analysts say about Careium AB?
        Careium AB’s analyst rating consensus is a Hold. This is based on the ratings of 0 Wall Streets Analysts.
          How can I buy shares of Careium AB?
          To buy shares of SE:CARE, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis